One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

BACKGROUND: This prospective, open-label, non-comparative, multicentre, long-term phase IV study is examining the efficacy and safety of somatropin [recombinant human growth hormone (rhGH)] in short children born small for gestational age (SGA) and its impact on the incidence of diabetes. This repor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Ther
Main Authors: Schwarz, Hans-Peter, Birkholz-Walerzak, Dorota, Szalecki, Mieczyslaw, Walczak, Mieczyslaw, Galesanu, Corina, Metreveli, David, Khan-Boluki, Jasmin, Schuck, Ellen
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254863/
https://ncbi.nlm.nih.gov/pubmed/24676989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-014-0014-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares